BDSX
HealthcareBiodesix, Inc.
$6.23
$-0.23 (-3.56%)
Jan 5, 2026
Price History (1Y)
Analysis
Biodesix, Inc. is a healthcare company operating in the diagnostics and research industry. With a market capitalization of $51.68M, the company maintains a relatively small scale compared to larger corporations in its sector. Biodesix has a workforce of 273 employees. The financial health of Biodesix remains unclear due to a lack of available data on key metrics such as revenue, net income, EBITDA, and free cash flow. Additionally, gross margin, operating margin, profit margin, return on equity, return on assets, debt to equity ratio, and current ratio are also not disclosed. The valuation context for Biodesix is characterized by a beta of 0.62, indicating moderate volatility compared to the market average. The company's 52-week high was $31.00, while its low stood at $3.44.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Biodesix, Inc.
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment testing to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR, GeneStrat NGS, and VeriStrat tests markets as part of IQLung testing strategy, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to guide treatment decisions. In addition, the company provides diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services for biopharmaceutical, life sciences, and diagnostic companies. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
Visit website →Key Statistics
- Market Cap
- $51.68M
- P/E Ratio
- N/A
- 52-Week High
- $31.00
- 52-Week Low
- $3.44
- Avg Volume
- 141.60K
- Beta
- 0.62
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NGM
- Country
- United States
- Employees
- 273